HHealth Read More UK Study Integrates PrecivityAD2 Blood Test for Alzheimer’s in Primary CareJuly 31, 2026 Researchers in the United Kingdom are integrating the PrecivityAD2 blood test from C2N Diagnostics into the Alzheimer’s disease…
HHealth Read More Codex Genetics Partners with C2N Diagnostics to Introduce the PrecivityAD2™ Blood Test in Hong Kong, Facilitating Access to Innovative Alzheimer’s Disease DiagnosticsMarch 10, 2026 HONG KONG, March 10, 2026 /PRNewswire/ — Codex Genetics, a leading precision diagnostics company headquartered in Hong Kong,…